Variability in the androgen response of prostate epithelium to 5α-reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer research, 2010 - AACR
Inhibitors of 5α-reductase (SRD5A) that lower intraprostatic levels of dihydrotestosterone
(DHT) reduce the overall incidence of prostate cancer (PCa), but there is significant variation …
(DHT) reduce the overall incidence of prostate cancer (PCa), but there is significant variation …
[PDF][PDF] Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb… - Cancer …, 2010 - rvaprostatecancersupport.org
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb… - Cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Inhibitors of 5alpha-reductase (SRD5A) that lower intraprostatic levels of
dihydrotestosterone (DHT) reduce the overall incidence of prostate cancer (PCa), but there …
dihydrotestosterone (DHT) reduce the overall incidence of prostate cancer (PCa), but there …
[引用][C] Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention
EA MOSTAGHEL, L GENG, I HOLCOMB… - Cancer research …, 2010 - pascal-francis.inist.fr
Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition:
Implications for Prostate Cancer Chemoprevention CNRS Inist Pascal-Francis CNRS …
Implications for Prostate Cancer Chemoprevention CNRS Inist Pascal-Francis CNRS …
Variability in the Androgen Response of Prostate Epithelium to 5 alpha-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer …, 2010 - hero.epa.gov
Inhibitors of 5 alpha-reductase (SRD5A) that lower intraprostatic levels of
dihydrotestosterone (DHT) reduce the overall incidence of prostate cancer (PCa), but there …
dihydrotestosterone (DHT) reduce the overall incidence of prostate cancer (PCa), but there …
[HTML][HTML] Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer …, 2010 - ncbi.nlm.nih.gov
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
[PDF][PDF] Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer Res, 2010 - researchgate.net
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
[PDF][PDF] Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer Res, 2010 - academia.edu
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer …, 2010 - europepmc.org
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
[PDF][PDF] Variability in the androgen response of prostate epithelium to 5-alpha reductase inhibition: implications for prostate cancer chemoprevention
EA Mostaghel, L Geng, I Holcomb, IM Coleman… - Cancer Res, 2010 - academia.edu
Androgens and the androgen receptor (AR) influence prostate carcinogenesis. Lowering
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …
intraprostatic dihydrotestosterone (DHT) by inhibiting 5-alpha-reductase (SRD5A) reduces …